Literature DB >> 18538185

Ventricular arrhythmias in normal hearts.

Shuaib Latif1, Sanjay Dixit, David J Callans.   

Abstract

Ventricular tachycardia in the structurally normal heart accounts for approximately 10% of cases. Although the overall prognosis is relatively good, with a benign course in most patients, these arrhythmias can lead to significant symptoms. Our understanding of these arrhythmias has progressed significantly, leading to effective therapies targeting their underlying mechanism. In many cases, catheter ablation is successful and the therapy of choice in patients who have sufficient symptoms. This article reviews outflow tract, idiopathic left ventricular, and automatic ventricular tachycardias.

Entities:  

Mesh:

Year:  2008        PMID: 18538185     DOI: 10.1016/j.ccl.2008.03.011

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  4 in total

1.  Long-term mode and timing of premature ventricular complex recurrence following successful catheter ablation.

Authors:  Derek Lee; Kurt S Hoffmayer; Jonathan C Hsu; Amir Schricker; Ulrika Birgersdotter-Green; Farshad Raissi; Gregory K Feld; David E Krummen
Journal:  J Interv Card Electrophysiol       Date:  2019-02-07       Impact factor: 1.900

2.  fQRS as a marker of granulomatous disease in patients presenting with ventricular tachycardia and normal left ventricular ejection fraction.

Authors:  Henri Roukoz; Mandar Shah; Lawrence Jesuraj Masilamani; Ajit Thachil; Prem K Jayakumar; David G Benditt; Calambur Narasimhan
Journal:  Indian Heart J       Date:  2015-04-30

3.  Successful catheter ablation of focal automatic left ventricular tachycardia presented with tachycardia-mediated cardiomyopathy.

Authors:  Hee-Woo Lee; Jin-Bae Kim; Boyoung Joung; Moon-Hyoung Lee; Sung-Soon Kim
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

4.  Calcium dysregulation increases right ventricular outflow tract arrhythmogenesis in rabbit model of chronic kidney disease.

Authors:  Shih-Yu Huang; Yao-Chang Chen; Yu-Hsun Kao; Yen-Yu Lu; Yung-Kuo Lin; Satoshi Higa; Shih-Ann Chen; Yi-Jen Chen
Journal:  J Cell Mol Med       Date:  2021-11-10       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.